Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
24-hour versus 72-hour perioperative antibiotic prophylaxis in head and neck free flap surgery
ACTRN12624000370505Phase 4Recruiting
- Sponsor
- Royal Melbourne Hospital
- Start
- May 2024
- Modality
- Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cefazolin, metronidazole and clindamycin in surgical site infection (SSI) (2 arms), sponsored by Royal Melbourne Hospital. Primary endpoint: Incidence of surgical site infections. Started May 2024; status: recruiting.
02
Drugs
cefazolinmetronidazoleclindamycin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on ACTRN12624000370505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624000370505.